These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 6175836

  • 1. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA, Beattie JM, Evenson ME, Needham KE, Mason DT.
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA, Needham KE, Evenson MK, Amsterdam EE, Mason DT.
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [Abstract] [Full Text] [Related]

  • 3. Management of refractory congestive heart failure with prazosin.
    Awan NA, Evenson MK, Needham KE, Mason DT.
    Am Heart J; 1981 Sep; 102(3 Pt 2):626-34. PubMed ID: 6267922
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA, Miller RR, DeMaria AN, Maxwell KS, Neumann A, Mason DT.
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA, Hermanovich J, Whitcomb C, Skinner P, Mason DT.
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral vasodilator therapy with prazosin in severe congestive heart failure.
    Awan NA, Mason DT.
    Am Heart J; 1981 May; 101(5):695-700. PubMed ID: 7223616
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
    Sharpe DN, Coxon R.
    Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure.
    Colucci WS, Holman BL, Wynne J, Carabello B, Malacoff R, Grossman W, Braunwald E.
    Am J Med; 1981 Jul; 71(1):75-80. PubMed ID: 6113759
    [Abstract] [Full Text] [Related]

  • 20. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE, Magorien RD, Triffon DW, Blanford MF, Unverferth DV, Leier CV.
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.